WHO chief scientist welcomes India’s decision to restart COVID-19 vaccine exports

New Delhi: Chief scientist of World Health Organization (WHO) Dr Soumya Swaminathan on Tuesday welcomed India’s decision to restart COVID-19 vaccine exports. She said that the decision will go long way to achieve global Vaccine Equity.

“COVAX welcomes the decision to restart Covid vaccine exports. Will go a long way to achieve global Vaccine Equity,” Soumya Swaminathan said in a tweet.

Union Minister of Health and Family Welfare Mansukh Mandaviya on Monday announced that in the fourth quarter this year, the Government of India will resume Vaccine Maitri, an initiative to provide Covid vaccines to countries around the world and also fulfil its responsibility under Covax.

“Under Vaccine Maitri, we will help the world and contribute to Covax in the fourth quarter,” Mandaviya said to reporters. He also announced that next month government is expecting more than 30 crore doses from vaccine manufacturers.

Health Minister estimated the target of the fourth quarter this year to be around 100 crores and highlighted that vaccination of own citizens is the topmost priority.

Meanwhile, with the administration of 96,46,778 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage exceeded 81.85 crores (81,85,13,827) as per provisional reports till 7 am on Tuesday, informed the Ministry of Health and Family Welfare.

The ministry said that this has been achieved through 80,35,135 sessions.

As per the data, as many as 1,03,69,386 healthcare workers have been inoculated with the first dose of COVID vaccine while 87,50,107 have been inoculated with both doses. The number of frontline workers vaccinated stands at 1,83,46,016 (first dose) and 1,45,66,593 (two doses).

Early this year, India halted vaccine exports as coronavirus cases surged in the country.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs